Treatment-Related Adverse Events Predict Improved Clinical Outcome in NSCLC Patients on KEYNOTE-001 at a Single Center

We retrospectively analyzed non-small cell lung cancer (NSCLC) patients from a single center treated with pembrolizumab on the KEYNOTE-001 trial and evaluated the association between treatment-related adverse events (trAEs) and clinical outcomes. Investigators reported AEs on trial and graded them a...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Cancer Immunol Res
Auteurs principaux: Lisberg, Aaron, Tucker, D. Andrew, Goldman, Jonathan W, Wolf, Brian, Carroll, James, Hardy, Ariana, Morris, Karolyn, Linares, Paulina, Adame, Carlos, Spiegel, Marshall L, Wells, Courtney, McKenzie, Jordan, Ledezma, Blanca, Mendenhall, Melody, Abarca, Phillip, Bornazyan, Krikor, Hunt, Jaime, Moghadam, Nima, Chong, Natalie, Nameth, Danielle, Marx, Caitlin, Madrigal, John, Vangala, Sitaram, Shaverdian, Narek, Elashoff, David, Garon, Edward B
Format: Artigo
Langue:Inglês
Publié: 2018
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6066474/
https://ncbi.nlm.nih.gov/pubmed/29382669
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2326-6066.CIR-17-0063
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires